{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:05:15Z","timestamp":1771599915435,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"European Project MM4TB","award":["260872"],"award-info":[{"award-number":["260872"]}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.drudis.2016.11.014","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T15:31:47Z","timestamp":1479915107000},"page":"576-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Target-based approaches for the discovery of new antimycobacterial drugs"],"prefix":"10.1016","volume":"22","author":[{"given":"Chiara","family":"Borsari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Venturelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Paola","family":"Costi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2016.11.014_bib0305","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/S1473-3099(16)00070-0","article-title":"Tuberculosis: advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers","volume":"16","author":"Wallis","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drudis.2016.11.014_bib0310","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrd4001","article-title":"Advances in the development of new tuberculosis drugs and treatment regimens","volume":"12","author":"Zumla","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2016.11.014_bib0315","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/TCRM.S37743","article-title":"New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline","volume":"10","author":"Leibert","year":"2014","journal-title":"Therapeut. Clin. Risk Manage."},{"key":"10.1016\/j.drudis.2016.11.014_bib0320","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/emmm.201201772","article-title":"Tuberculosis drug discovery in the post-post-genomic era","volume":"6","author":"Lechartier","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.drudis.2016.11.014_bib0325","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2174\/138620712802650487","article-title":"In silico discovery and virtual screening of multi-target inhibitors for proteins in Mycobacterium tuberculosis","volume":"15","author":"Speck-Planche","year":"2012","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.drudis.2016.11.014_bib0330","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ejps.2013.01.011","article-title":"New insights toward the discovery of antibacterial agents: multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs","volume":"48","author":"Speck-Planche","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2016.11.014_bib0335","first-page":"e427","article-title":"Multi-objective optimization methods in drug design","volume":"10","author":"Christos","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2016.11.014_bib0340","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.gene.2015.12.054","article-title":"Comparative analyses of the proteins from Mycobacterium tuberculosis and human genomes: identification of potential tuberculosis drug targets","volume":"579","author":"Sridhar","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.drudis.2016.11.014_bib0345","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drudis.2016.11.014_bib0350","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.drup.2015.10.003","article-title":"Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: novel strategies to overcome cancer chemoresistance","volume":"23","author":"Taddia","year":"2015","journal-title":"Drug Res. Updates"},{"key":"10.1016\/j.drudis.2016.11.014_bib0355","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.1021\/jm4012033","article-title":"Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis","volume":"56","author":"Shirude","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0360","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/cb0500042","article-title":"High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis","volume":"1","author":"Sullivan","year":"2006","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.drudis.2016.11.014_bib0365","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/jm501029r","article-title":"Design, synthesis, and evaluation of new thiadiazole-based direct inhibitors of enoyl acyl carrier protein reductase (InhA) for the treatment of tuberculosis","volume":"58","author":"Sink","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0370","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1021\/ci400202t","article-title":"Discovery of new inhibitors of Mycobacterium tuberculosis InhA enzyme using virtual screening and a 3D-pharmacophore-based approach","volume":"53","author":"Pauli","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.drudis.2016.11.014_bib0375","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.5b01620","article-title":"In silico driven design and synthesis of rhodanine derivatives as novel antibacterials targeting the enoyl reductase InhA","author":"Slepikas","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0380","doi-asserted-by":"crossref","first-page":"11565","DOI":"10.1073\/pnas.1302114110","article-title":"Diaryl coumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32","volume":"110","author":"Stanley","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.11.014_bib0385","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bcp.2013.05.004","article-title":"Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones","volume":"86","author":"Lee","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2016.11.014_bib0390","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.carres.2011.05.024","article-title":"Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU","volume":"346","author":"Li","year":"2011","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.drudis.2016.11.014_bib0395","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.tube.2015.06.003","article-title":"High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU","volume":"95","author":"Rani","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.drudis.2016.11.014_bib0400","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00894-015-2704-3","article-title":"Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity","volume":"21","author":"Soni","year":"2015","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.drudis.2016.11.014_bib0405","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/acscombsci.5b00019","article-title":"Computationally guided identification of novel Mycobacterium tuberculosis GlmU inhibitory leads, their optimization, and in vitro validation","volume":"18","author":"Mehra","year":"2016","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.drudis.2016.11.014_bib0410","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.1171583","article-title":"Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis","volume":"324","author":"Makarov","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.drudis.2016.11.014_bib0415","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1128\/AAC.00778-15","article-title":"The 8-pyrrole-benzothiazinones are noncovalent inhibitors of DprE1 from Mycobacterium tuberculosis","volume":"59","author":"Makarov","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.11.014_bib0420","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/emmm.201303575","article-title":"Towards a new combination therapy for tuberculosis with next generation benzothiazinones","volume":"6","author":"Makarov","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.drudis.2016.11.014_bib0425","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1016\/j.bmc.2015.11.017","article-title":"Discovery of benzothiazoles as antimycobacterial agents: synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-\u03b2-d-ribose 2\u2032-oxidase","volume":"23","author":"Landge","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0430","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/cb5007163","article-title":"2-Carboxyquinoxalines kill Mycobacterium tuberculosis through noncovalent inhibition of DprE1","volume":"10","author":"Neres","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.drudis.2016.11.014_bib0435","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1021\/jm401382v","article-title":"Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo","volume":"56","author":"Shirude","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0440","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1021\/jm5005978","article-title":"4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity","volume":"57","author":"Naik","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0445","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1021\/jm5002937","article-title":"Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity","volume":"57","author":"Panda","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0450","doi-asserted-by":"crossref","first-page":"12830","DOI":"10.1038\/srep12830","article-title":"Crystal structures of Mycobacterium tuberculosis GlgE and complexes with non-covalent inhibitors","volume":"5","author":"Lindenberger","year":"2015","journal-title":"Scientific Rep."},{"key":"10.1016\/j.drudis.2016.11.014_bib0455","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.bmc.2013.12.058","article-title":"Synthesis of a C-phosphonate mimic of maltose-1-phosphate and inhibition studies on Mycobacterium tuberculosis GlgE","volume":"22","author":"Veleti","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0460","doi-asserted-by":"crossref","first-page":"9444","DOI":"10.1021\/jo501481r","article-title":"Synthesis of a poly-hydroxypyrolidine-based inhibitor of Mycobacterium tuberculosis GlgE","volume":"79","author":"Veleti","year":"2014","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0465","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.1039\/C5OB00867K","article-title":"Synthesis of 2-deoxy-2,2-difluoro-\u03b1-maltosyl fluoride and its X-ray structure in complex with Streptomyces coelicolor GlgEI-V279S","volume":"13","author":"Thanna","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0470","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bmcl.2015.12.083","article-title":"Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido [4\u2032,3\u2032:4,5]thieno [2,3-d]pyrimidin-4(3H)-one Schiff bases","volume":"26","author":"Narender","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2016.11.014_bib0475","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejmech.2013.08.036","article-title":"Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo [4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors","volume":"69","author":"Samala","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0480","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.bmc.2014.01.030","article-title":"Development of novel tetrahydrothieno [2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads","volume":"22","author":"Samala","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0485","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.bmc.2014.05.038","article-title":"Identification and development of 2-methylimidazo [1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors","volume":"22","author":"Samala","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0490","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bmc.2014.12.060","article-title":"Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis","volume":"23","author":"Singh","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0495","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijantimicag.2012.09.012","article-title":"Biological evaluation of novel substituted chloroquinolines targeting mycobacterial ATP synthase","volume":"41","author":"Khan","year":"2013","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.drudis.2016.11.014_bib0500","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1039\/C5MD00589B","article-title":"Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway","volume":"7","author":"Tantry","year":"2015","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.drudis.2016.11.014_bib0505","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejmech.2013.09.025","article-title":"Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors","volume":"70","author":"Jeankumar","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0510","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1073\/pnas.1525047113","article-title":"Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis","volume":"113","author":"Blower","year":"2016","journal-title":"Pro. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.11.014_bib0515","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cbdd.12152","article-title":"Identification of novel gyrase B inhibitors as potential anti-TB drugs: homology modelling, hybrid virtual screening and molecular dynamics simulations","volume":"82","author":"Maharaj","year":"2013","journal-title":"Chem. Biol. Drug. Des."},{"key":"10.1016\/j.drudis.2016.11.014_bib0520","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1021\/jm500432n","article-title":"Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis","volume":"57","author":"Hameed","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0525","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijantimicag.2013.12.006","article-title":"Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: scaffold hopping from known antibacterial leads","volume":"43","author":"Jeankumar","year":"2014","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.drudis.2016.11.014_bib0530","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.1021\/jm401268f","article-title":"Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA gyrase B","volume":"56","author":"Kale","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0535","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bmcl.2013.12.080","article-title":"Thiazolopyridoneureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy","volume":"24","author":"Kale","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2016.11.014_bib0540","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejmech.2014.08.018","article-title":"Extending the N-linked aminopiperidine class to the mycobacterial gyrase domain: pharmacophore mapping from known antibacterial leads","volume":"85","author":"Bobesh","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0545","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.bmc.2015.03.004","article-title":"Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors","volume":"23","author":"Medapi","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0550","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1016\/j.bmc.2014.06.041","article-title":"Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis","volume":"22","author":"Renuka","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0555","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1016\/j.bmc.2014.10.016","article-title":"An efficient synthesis and biological screening of benzofuran and benzo [d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition","volume":"22","author":"Reddy","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0560","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1039\/C4OB02049A","article-title":"Enabling the (3+2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling","volume":"13","author":"Jeankumar","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0565","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.bmc.2016.01.011","article-title":"Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors","volume":"24","author":"Medapi","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0570","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/cmdc.201300146","article-title":"Discovery of an acyclic nucleoside phosphonate that inhibits Mycobacterium tuberculosis ThyX based on the binding mode of a 5-alkynyl substrate analogue","volume":"8","author":"Parchina","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.drudis.2016.11.014_bib0575","doi-asserted-by":"crossref","first-page":"9269","DOI":"10.1021\/acs.jmedchem.6b00977","article-title":"Virtual screening and X-ray crystallography identify non-substrate analog inhibitors of flavin-dependent thymidylate synthase","volume":"59","author":"Luciani","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0580","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1099\/mic.0.053983-0","article-title":"Mycobacterium tuberculosis thymidylate synthase gene thyX is essential and potentially bifunctional, while thyA deletion confers resistance to p-aminosalicylic acid","volume":"158","author":"Fivian-Hughes","year":"2012","journal-title":"Microbiology"},{"key":"10.1016\/j.drudis.2016.11.014_bib0585","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1021\/jm2004688","article-title":"Synthesis and evaluation of 5-substituted 2\u2032-deoxyuridine monophosphate analogues as inhibitors of flavin-dependent thymidylate synthase in Mycobacterium tuberculosis","volume":"54","author":"K\u00f6gler","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0590","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1016\/j.bmc.2013.07.003","article-title":"Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides","volume":"21","author":"Shmalenyuk","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0595","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.1016\/j.bmc.2015.09.053","article-title":"Synthesis and evaluation of C-5 modified 2\u2032-deoxyuridine monophosphates as inhibitors of M. tuberculosis thymidylate synthase","volume":"23","author":"Alexandrova","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.11.014_bib0600","doi-asserted-by":"crossref","first-page":"27792","DOI":"10.1038\/srep27792","article-title":"Predictive modeling targets thymidylate synthase ThyX in Mycobacterium tuberculosis","volume":"6","author":"Djaout","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644616304329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644616304329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:29:38Z","timestamp":1761222578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644616304329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1359644616304329"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2016.11.014","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Target-based approaches for the discovery of new antimycobacterial drugs","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2016.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}